Powerful Allies and Weak Consensus: Towards a Deeper Understanding of how Health-Harming Industries Seek to Influence Global Health Governance; Comment on “Competing Frames in Global Health Governance: An Analysis of Stakeholder Influence on the Political Declaration on Non-Communicable Diseases”

Document Type : Commentary

Authors

1 Faculty of Public Health & Policy, London School of Hygiene and Tropical Medicine, London, UK

2 MRC Epidemiology Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK

Abstract

Suzuki et al have identified commonalities in the policy positions adopted at a global forum by commercial sector actors and high-income countries (HICs), on the one hand, and non-governmental organizations (NGOs) and lowand middle-income countries (LMICs), on the other, in ways that may allow commercial sector actors to block or delay evidence-based policies through the creation of political controversy. The ability of industry actors to draw on the support of the most politically and economically powerful countries for their favoured policy agenda is an important contribution to understanding the dynamics of global health governance in the area of non-communicable diseases (NCDs) and beyond. Here we assess the relevance of this paper for the field of corporate actors’ research and the potential avenues this opens up for further study. More specifically we emphasize the need for comparative, cross disciplinary research to examine the power of heath-harming industries and the relevance of these findings for decolonizing global health.

Keywords


  1. Suzuki M, Webb D, Small R. Competing frames in global health governance: an analysis of stakeholder influence on the political declaration on non-communicable diseases. Int J Health Policy Manag. 2021. doi:34172/ijhpm.2020.257
  2. Ralston R, Hil SE, da Silva Gomes F, Collin J. Towards preventing and managing conflict of interest in nutrition policy? an analysis of submissions to a consultation on a draft WHO tool. Int J Health Policy Manag. 2021;10(5):255-265. doi:34172/ijhpm.2020.52
  3. Maani N, Van Schalkwyk MC, Petticrew M, Ralston R, Collin J. The new WHO Foundation - global health deserves better. BMJ Glob Health. 2021;6(2):e004950. doi:1136/bmjgh-2021-004950
  4. Hawkins B, Holden C, Eckhardt J, Lee K. Reassessing policy paradigms: a comparison of the global tobacco and alcohol industries. Glob Public Health. 2018;13(1):1-19. doi:1080/17441692.2016.1161815
  5. Thow AM, Jones A, Huckel Schneider C, Labonté R. Increasing the public health voice in global decision-making on nutrition labelling. Global Health. 2020;16(1):3. doi:1186/s12992-019-0533-3
  6. Lee K, Freudenberg N. Addressing the commercial determinants of health begins with clearer definition and measurement. Glob Health Promot. 2020;27(2):3-5. doi:1177/1757975920931249
  7. McKee M, Stuckler D. Revisiting the corporate and commercial determinants of health. Am J Public Health. 2018;108(9):1167-1170. doi:2105/ajph.2018.304510
  8. Lacy-Nichols J, Marten R. Power and the commercial determinants of health: ideas for a research agenda. BMJ Glob Health. 2021;6(2):e003850. doi:1136/bmjgh-2020-003850
  9. Sell SK. Private Power, Public Law: The Globalization of Intellectual Property Rights. Cambridge: Cambridge University Press; 2003. doi:1017/cbo9780511491665
  10. Michaels D. Doubt is Their Product: How Industry’s Assault on Science Threatens Your Health. Oxford: Oxford University Press; 2008.
  11. Hawkins BR, McCambridge J. Partners or opponents? alcohol industry strategy and the 2016 revision of the U.K. low-risk drinking guidelines. J Stud Alcohol Drugs. 2021;82(1):84-92. doi:15288/jsad.2021.82.84
  12. Büyüm AM, Kenney C, Koris A, Mkumba L, Raveendran Y. Decolonising global health: if not now, when? BMJ Glob Health. 2020;5(8):e003394. doi:1136/bmjgh-2020-003394
  13. Pai M. Global Health Still Mimics Colonial Ways: Here’s How to Break the Pattern. The Conversation; 2019.
  14. Nguyen Thi Yen C, Hermoso C, Laguilles EM, et al. Vietnam's success story against COVID-19. Public Health Pract (Oxf). 2021;2:100132. doi:1016/j.puhip.2021.100132
  15. O'Brien P. Australia's double standard on Thailand's alcohol warning labels. Drug Alcohol Rev. 2013;32(1):5-10. doi:1111/j.1465-3362.2012.00485.x

Articles in Press, Corrected Proof
Available Online from 21 September 2021
  • Receive Date: 17 July 2021
  • Revise Date: 05 September 2021
  • Accept Date: 19 September 2021